VERA - Vera Therapeutics GAAP EPS of -$0.80 misses by $0.20
2023-05-11 12:12:12 ET
- Vera Therapeutics press release ( NASDAQ: VERA ): Q1 GAAP EPS of -$0.80 misses by $0.20 .
- $197.2 million cash, cash equivalents, and marketable securities as of March 31, 2023 expected to fund operations to early 2026
For further details see:
Vera Therapeutics GAAP EPS of -$0.80 misses by $0.20